9:16 19/02/2017 The Arena Pharmaceuticals, Inc. (ARNA) Stock Rating Decreased by the Zacks ...
The Arena Pharmaceuticals, Inc. (ARNA) Stock Rating Decreased by the Zacks ...
DailyQuint - 2 hours ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Tuesday.

18:48 18/02/2017 Analyst Research and Ratings: Arena Pharmaceuticals, Inc. (ARNA), Zendesk, Inc ...
Analyst Research and Ratings: Arena Pharmaceuticals, Inc. (ARNA), Zendesk, Inc ...
TWN - 17 hours ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) tinted loss of 0% (0 points) to US$1.49. The volume of 0.98 Million shares climbed down over an trading activity of 1.63 Million shares.

22:30 15/02/2017 Arena Pharmaceuticals Inc. (ARNA) Soars 5.48% on February 15
Arena Pharmaceuticals Inc. (ARNA) Soars 5.48% on February 15
Equities.com - Feb 15, 2017
Arena Pharmaceuticals Inc. (ARNA) had a good day on the market for Wednesday February 15 as shares jumped 5.48% to close at $1.54.
Upcoming Earnings Results: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - The Voice Registrar
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Analyst Coverage - NewsDen

10:09 15/02/2017 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Files An 8-K Departure of Directors ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Files An 8-K Departure of Directors ...
Market Exclusive - Feb 15, 2017
Effective February 13, 2017, the board of directors (the “Board”) of Arena Pharmaceuticals, Inc. (the “Company”) increased the size of the Board from eight directors to eleven directors and appointed Drs.

13:30 14/02/2017 Arena Pharmaceuticals Appoints Three New Members to Board of Directors
Arena Pharmaceuticals Appoints Three New Members to Board of Directors
PR Newswire (press release) - Feb 14, 2017
SAN DIEGO, Feb. 14, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced the appointment of three new members to the company's Board of Directors.

8:26 10/02/2017 Forward Earnings Estimate of Arena Pharmaceuticals, Inc.(ARNA)
Forward Earnings Estimate of Arena Pharmaceuticals, Inc.(ARNA)
Highland Mirror - Feb 10, 2017
Arena Pharmaceuticals, Inc. has received $-0.09 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 4 Financial Advisor in the Stock Trading Firms.

13:30 09/02/2017 Arena Pharmaceuticals Announces Three Upcoming Presentations at the 12th ...
Arena Pharmaceuticals Announces Three Upcoming Presentations at the 12th ...
PR Newswire (press release) - Feb 9, 2017
SAN DIEGO, Feb. 9, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that Dr. Scott Lee and Professor Tanja Kühbacher will present data on etrasimod (APD334) at the 12th Congress of European Crohn's and Colitis ...

12:56 01/02/2017 Schueneman v. Arena Pharmaceuticals: Sufficient Pleading of Scienter
Schueneman v. Arena Pharmaceuticals: Sufficient Pleading of Scienter
The Race to the Bottom - Feb 1, 2017
In Schueneman v. Arena Pharmaceuticals, Inc., 840 F.3d 698 (9th Cir. 2016), the United States Court of Appeals for the Ninth Circuit reversed the District Court's ruling of summary judgment for Arena Pharmaceuticals, Inc. (“Defendant”) based on an ...

23:03 31/01/2017 Arena Pharmaceuticals Inc. (ARNA) Moves Higher on Volume Spike for February 01
Arena Pharmaceuticals Inc. (ARNA) Moves Higher on Volume Spike for February 01
Equities.com - Jan 31, 2017
Arena Pharmaceuticals Inc. (ARNA) traded on unusually high volume on Feb. 01, as the stock gained 4.55% to close at $1.61. On the day, Arena Pharmaceuticals Inc. saw 3.92 million shares trade hands on 10,365 trades. Considering that the stock averages ...

22:30 31/01/2017 Arena Pharmaceuticals Inc. (ARNA) Soars 6.21% on January 31
Arena Pharmaceuticals Inc. (ARNA) Soars 6.21% on January 31
Equities.com - Jan 31, 2017
Arena Pharmaceuticals Inc. (ARNA) had a good day on the market for Tuesday January 31 as shares jumped 6.21% to close at $1.54.